05/04/2021
12:58 PM | Schoenberg Mark (Reporting)
Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/27/2021
12:44 PM | Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2021
4:19 PM | Belldegrun Arie (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2021
4:18 PM | Nussbaum Ran (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2021
7:13 AM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2021
7:10 AM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2021
7:10 AM | UroGen Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/11/2021
6:28 AM | MENORA MIVTACHIM HOLDINGS LTD. (Filed by)
UroGen Pharma (Subject)
| Form SC 13G/A
| |
02/03/2021
12:13 PM | UroGen Pharma (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
02/02/2021
2:55 PM | Smith Jason Drew (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/02/2021
1:54 PM | Barrett Elizabeth A. (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2021
1:53 PM | Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2021
7:17 AM | BlackRock Inc. (Filed by)
UroGen Pharma (Subject)
| Form SC 13G/A
| |
01/26/2021
4:20 PM | Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2021
7:03 AM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/11/2021
7:31 AM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2020
4:27 PM | Barrett Elizabeth A. (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2020
2:59 PM | Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2020
3:35 PM | Barrett Elizabeth A. (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2020
3:05 PM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/17/2020
3:15 PM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2020
7:13 AM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2020
6:40 AM | UroGen Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/28/2020
1:12 PM | Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2020
2:41 PM | PFREUNDSCHUH PETER P. (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2020
3:37 PM | Henderson Molly (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2020
3:36 PM | Henderson Molly (Reporting)
UroGen Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/05/2020
3:35 PM | Smith Jason Drew (Reporting)
UroGen Pharma (Issuer)
| Form 4/A
| |
09/10/2020
11:14 AM | Smith Jason Drew (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2020
11:13 AM | Smith Jason Drew (Reporting)
UroGen Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/09/2020
7:02 AM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/08/2020
3:48 PM | Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2020
1:37 PM | PFREUNDSCHUH PETER P. (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2020
7:01 AM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2020
4:08 PM | UroGen Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/10/2020
6:35 AM | UroGen Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/10/2020
6:20 AM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/28/2020
4:34 PM | PFREUNDSCHUH PETER P. (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2020
4:32 PM | Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2020
5:43 PM | Tomasello Shawn (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2020
5:41 PM | Nussbaum Ran (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2020
5:40 PM | Holden Stuart (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2020
5:39 PM | FALBERG KATHRYN E (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2020
5:38 PM | Cohen Fred E (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2020
5:36 PM | BUTITTA CYNTHIA M (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2020
5:35 PM | Belldegrun Arie (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2020
1:31 PM | Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2020
3:44 PM | PFREUNDSCHUH PETER P. (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2020
8:17 AM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2020
12:07 PM | Barrett Elizabeth A. (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2020
6:03 AM | UroGen Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2020
5:53 AM | UroGen Pharma (Filer)
| Form DEFA14A
| |
04/29/2020
5:42 AM | UroGen Pharma (Filer)
| Form DEF 14A
| |
04/28/2020
12:53 PM | Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2020
12:51 PM | PFREUNDSCHUH PETER P. (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2020
12:43 PM | Mullennix Stephen (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2020
8:29 PM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/23/2020
6:31 AM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2020
4:28 PM | Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2020
6:33 AM | UroGen Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/24/2020
3:53 PM | PFREUNDSCHUH PETER P. (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2020
1:33 PM | Mullennix Stephen (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2020
3:27 PM | UroGen Pharma (Subject)
Wildcat Capital Management, LLC (Filed by)
| Form SC 13G/A
| |
02/13/2020
12:54 PM | Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
| Form 3/A
| |
02/13/2020
12:47 PM | Belldegrun Arie (Reporting)
UroGen Pharma (Issuer)
| Form 3/A
| |
02/04/2020
11:40 AM | PFREUNDSCHUH PETER P. (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2020
11:39 AM | Mullennix Stephen (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2020
11:38 AM | Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2020
11:36 AM | Barrett Elizabeth A. (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2020
4:15 PM | PFREUNDSCHUH PETER P. (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2020
4:14 PM | Mullennix Stephen (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2020
4:10 PM | Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2020
2:11 PM | UroGen Pharma (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
01/07/2020
5:30 PM | Barrett Elizabeth A. (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2020
11:15 PM | UroGen Pharma (Filer)
| Form EFFECT
| |
01/02/2020
3:50 PM | UroGen Pharma (Filer)
| Form 424B5
| |
12/20/2019
3:31 PM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2019
12:44 PM | Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2019
3:16 PM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2019
2:34 PM | Barrett Elizabeth A. (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2019
12:35 PM | Barrett Elizabeth A. (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2019
12:29 PM | PFREUNDSCHUH PETER P. (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2019
7:49 PM | Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2019
6:32 PM | Barrett Elizabeth A. (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2019
3:04 PM | Mullennix Stephen (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2019
7:06 AM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2019
6:32 AM | UroGen Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2019
6:01 AM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2019
3:02 PM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2019
3:16 PM | UroGen Pharma (Subject)
Wildcat Capital Management, LLC (Filed by)
| Form SC 13G
| |
09/24/2019
4:20 PM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2019
8:27 AM | Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2019
12:31 PM | PFREUNDSCHUH PETER P. (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2019
2:38 PM | Mullennix Stephen (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2019
7:32 AM | UroGen Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2019
7:16 AM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2019
4:11 PM | UroGen Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/07/2019
4:00 PM | UroGen Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2019
5:21 PM | Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2019
4:02 PM | Tomasello Shawn (Reporting)
UroGen Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
